HSA Approval

DHACTULOSE SYRUP

Approval Number

SIN11494P

Drug Name

DHACTULOSE SYRUP

Product Name

DHACTULOSE SYRUP

Approval Date

April 25, 2001

Registrant

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Licence Holder

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Regulatory Information

Registrant

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Licence Holder

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

General Sale List

Formulation Information

Dosage Form

SYRUP

Route of Administration

ORAL

Medical Information

ATC Code

A06AD11

ATC Item Name

lactulose

Manufacturer Information

Pharmaceutical Manufacturer

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Manufacturers

PT Actavis Indonesia

Active Ingredients

Ingredient Name

LACTULOSE

Strength

3.35 g/5 ml

Drug MonographLactulose

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

AI-Powered Research

Premium Access

DHACTULOSE SYRUP

Regulatory Information

Formulation Information

Medical Information

Manufacturer Information

Active Ingredients

MedPath

Product

Company

Legal